ctrl K

Price Alert

Protagenic Therapeutics I... (PTIX)

NASDAQ: PTIX · Real-Time Price · USD

2.40

-0.16 (-6.25%)

At close: Aug 20, 2025, 9:42 AM

Protagenic Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.84M	1.29M	215.19K	541.17K
Short-Term Investments	n/a	2.77M	7.76M	9.83M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a
Total Current Assets	1.88M	4.2M	8.04M	11.06M
Property-Plant & Equipment	73.05K	123.33K	1.77K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	73.05K	123.33K	1.77K	n/a
Total Assets	1.96M	4.32M	8.04M	11.06M
Account Payables	102.96K	113.8K	155.49K	278.96K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	344.23K	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a
Total Current Liabilities	942.76K	655.25K	1.12M	799.53K
Long-Term Debt	n/a	n/a	n/a	318.43K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	318.43K
Total Liabilities	942.76K	655.25K	1.12M	1.12M
Total Debt	n/a	n/a	344.23K	318.43K
Common Stock	725.00	444.00	434.00	1.72K
Retained Earnings	-36.3M	-30.78M	-25.78M	-22.22M
Comprehensive Income	-129.85K	-113.55K	-676.91K	-248.35K
Shareholders Equity	1.01M	3.67M	6.92M	9.94M
Total Investments	n/a	2.77M	7.76M	9.83M